Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FC80Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,323
Award facts
- Contract value 100% obligated
- $59,322.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,322.56 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with performance executed from the contractor's Conshohocken, Pennsylvania location. The award, issued on August 21, 2025, with completion targeted for August 22, 2025, was competitively awarded under firm fixed-price terms with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.999 billion and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to federal medical procurement systems, particularly supporting military and veteran healthcare through the DLA's Medical Supply Chain. The company's substantial IDC with DLA Troop Support enables delivery of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Eliquis, an anticoagulant medication, reflects the contractor's ongoing role in fulfilling essential pharmaceutical requirements within the federal health system. AmerisourceBergen's federal contract portfolio demonstrates consistent competitive performance on non-set-aside awards across varying order values, positioning the company as a key vendor in the DLA's pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DB25FC80Y?
SPE2DB25FC80Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FC80Y worth?
The government has obligated $59,323 on SPE2DB25FC80Y.
Is contract SPE2DB25FC80Y an order under another contract?
Yes. SPE2DB25FC80Y is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC80Y competed?
The extent of competition for SPE2DB25FC80Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award